Search

Your search keyword '"Tellurium pharmacokinetics"' showing total 46 results

Search Constraints

Start Over You searched for: Descriptor "Tellurium pharmacokinetics" Remove constraint Descriptor: "Tellurium pharmacokinetics"
46 results on '"Tellurium pharmacokinetics"'

Search Results

1. Bioaccessibility as a determining factor in the bioavailability and toxicokinetics of cadmium compounds.

2. preADMET analysis and clinical aspects of dogs treated with the Organotellurium compound RF07: A possible control for canine visceral leishmaniasis?

3. PET and SPECT imaging of the brain: a review on the current status of nuclear medicine in Japan.

4. Methods for analyzing tellurium imaging mass cytometry data.

5. Biodistribution and Systemic Effects in Mice Following Intravenous Administration of Cadmium Telluride Quantum Dot Nanoparticles.

6. Evaluation of Quantum Dot Skin Penetration in Porcine Skin: Effect of Age and Anatomical Site of Topical Application.

7. Use of Iodine-131 to Tellurium-132 Ratios for Assessing the Relationships between Human Inhaled Radioactivity and Environmental Monitoring after the Accident in Fukushima.

8. Cadmium Telluride Quantum Dots as a Fluorescence Marker for Adipose Tissue Grafts.

9. Isotopologous Organotellurium Probes Reveal Dynamic Hypoxia In Vivo with Cellular Resolution.

10. On the role of a specific insert in acetate permeases (ActP) for tellurite uptake in bacteria: Functional and structural studies.

11. Selective inhibition of liver cancer growth realized by the intrinsic toxicity of a quantum dot-lipid complex.

12. Cadmium sulfate and CdTe-quantum dots alter DNA repair in zebrafish (Danio rerio) liver cells.

13. Degradation of aqueous synthesized CdTe/ZnS quantum dots in mice: differential blood kinetics and biodistribution of cadmium and tellurium.

14. Probing site-exclusive binding of aqueous QDs and their organelle-dependent dynamics in live cells by single molecule spectroscopy.

15. Estimation of Te-132 distribution in Fukushima Prefecture at the early stage of the Fukushima Daiichi Nuclear Power Plant reactor failures.

16. Distribution of artificial radionuclides in abandoned cattle in the evacuation zone of the Fukushima Daiichi nuclear power plant.

17. Hydrodynamic size-dependent cellular uptake of aqueous QDs probed by fluorescence correlation spectroscopy.

18. Toxicity of CdTe quantum dots on yeast Saccharomyces cerevisiae.

19. Synthesis of NAC capped near infrared-emitting CdTeS alloyed quantum dots and application for in vivo early tumor imaging.

20. Effects of long-term exposure of gelatinated and non-gelatinated cadmium telluride quantum dots on differentiated PC12 cells.

21. Multifactorial determinants that govern nanoparticle uptake by human endothelial cells under flow.

22. Liposome encapsulation of thiol-capped CdTe quantum dots for enhancing the intracellular delivery.

23. Quantum dots affect expression of CD133 surface antigen in melanoma cells.

24. Distinct uptake of tellurate from selenate in a selenium accumulator, Indian mustard (Brassica juncea).

25. Metabolism of tellurium, antimony and germanium simultaneously administered to rats.

26. The chemical fate of the Cd/Se/Te-based quantum dot 705 in the biological system: toxicity implications.

27. Comparison of distribution and metabolism between tellurium and selenium in rats.

28. The fate of MAb-targeted Cd(125m)Te/ZnS nanoparticles in vivo.

29. Influence of rainfall characteristics on elimination of aerosols of cesium, strontium, barium and tellurium deposited on grassland.

30. Individual thyroid dose estimation for a case-control study of Chernobyl-related thyroid cancer among children of Belarus-part I: 131I, short-lived radioiodines (132I, 133I, 135I), and short-lived radiotelluriums (131MTe and 132Te).

31. Tellurite uptake by cells of the facultative phototroph Rhodobacter capsulatus is a Delta pH-dependent process.

32. Reduction of potassium tellurite to elemental tellurium and its effect on the plasma membrane redox components of the facultative phototroph Rhodobacter capsulatus.

33. Biokinetics of radiotellurium in rats.

34. Contributions of short-lived radioiodines to thyroid doses received by evacuees from the Chernobyl area estimated using early in vivo activity measurements.

35. Comparative study on the bioactivation mechanisms and cytotoxicity of Te-phenyl-L-tellurocysteine, Se-phenyl-L-selenocysteine, and S-phenyl-L-cysteine.

36. Binding of tellurium to hepatocellular selenoproteins during incubation with inorganic tellurite: consequences for the activity of selenium-dependent glutathione peroxidase.

37. Evidence for the involvement of vacuolar activity in metal(loid) tolerance: vacuolar-lacking and -defective mutants of Saccharomyces cerevisiae display higher sensitivity to chromate, tellurite and selenite.

38. In vivo and in vitro cloning and phenotype characterization of tellurite resistance determinant conferred by plasmid pTE53 of a clinical isolate of Escherichia coli.

39. The Na+/e- stoichiometry of the Na+-motive NADH:quinone oxidoreductase in Vibrio alginolyticus.

40. Biochemistry of tellurium.

41. Use of INAA to study the interaction between Se and Te in cells of Saccharomyces cerevisiae.

42. Influence of the administered mass of tellurium on plasma clearance in rabbits.

43. Renal excretion of tellurium after peroral administration of tellurium in different forms to healthy human volunteers.

44. Stable isotopes for determining biokinetic parameters of tellurium in rabbits.

45. Biochemical and biophysical analysis of plasmid pMJ600-encoded tellurite [TeO2(3-)] resistance.

46. Tellurium-intoxication.

Catalog

Books, media, physical & digital resources